Stanford invests in treatment of Relapsing Fever-induced B cell dysimmunity (Great Imitators)
Mort Zuckerman
ca...@drcarolgoodheart.com, lPick...@cdc.gov, Durlan...@yale.edu,
Aa...@columbia.edu, gary_w...@nymc.edu,
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu, edi...@greenwich-post.com,
harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, dpr...@stmartin.edu, saint....@sbcglobal.net
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov,
richar...@yale.edu, harol...@yale.edu, james.p...@yale.edu,
inq...@aldf.com, ly...@idsociety.org, meganm...@theatlantic.com
Subject: Stanford invests in treatment of Relapsing Fever-induced B
cell dysimmunity (Great Imitators)
Date: Jun 24, 2010 6:37 AM
B cell Dysimmunity:
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=15991605
B cell Dysimmunity as a result of OspA-
activated Epstein-Barr:
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=20535037
Stanford take a large step over this
pile of intellectual waste produced by
the Israeli Infectious Diseases (Bioweapons
Blackmail) Lobby OKA IDSociety.org/Yale:
http://www.mercurynews.com/peninsula/ci_15363231?nclick_check=1
Four Stanford University School of Medicine researchers have been
awarded about $5.6 million for stem cell research projects.
Specifically, the California Institute for Regenerative Medicine is
funding projects that aim to discover ways to overcome immune system
rejection of transplanted stem cells. The institute is the state stem
cell agency created by Proposition 71, and on Tuesday it approved $25
million for 19 projects.
According to the institute, using cells derived from stem cells to
replace lost or damaged tissue is a major goal of stem cell research,
but it is possible the immune system could potentially reject those
cells, similar to how an immune system can reject a transplanted
organ.
Three-year grants, each of about $1.4 million, were awarded to four
Stanford researchers: Chris Contag, an associate professor of
pediatrics and of microbiology and immunology; Robert Negrin, a
professor of medicine and chief of the university's blood and bone
marrow transplant program; Judith Shizuru, associate professor of
medicine; and Kenneth Weinberg, a professor of pediatric cancer and
blood diseases and member of Stanford's Cancer Center.
Separately, $885,475 was awarded to Husein Hadeiba of the Palo Alto
Institute for Research and Education, which facilitates research and
education activities at the VA Palo Alto Health Care System.
The California Institute for Regenerative Medicine has provided
Stanford University with a total of
Advertisement
about $173 million for various projects since the institute was
established in November 2004.
E-mail Jesse Dungan at jdu...@dailynewsgroup.com.
===================================================
KMDickson
http://www.actionlyme.org
http://www.relapsingfever.org
"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci